LLY Jan 2025 280.000 call
| Previous Close | 269.36 |
| Open | 269.36 |
| Bid | 304.50 |
| Ask | 308.00 |
| Strike | 280.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 171.03 - 269.36 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 15 |
BloombergObesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
(Bloomberg) -- The global market for novel weight-loss drugs like Novo Nordisk A/S’s Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications.Most Read from BloombergChina’s Ultra-Rich Gen Zs Flock Home as Global Tensions RiseTreasuries Halt Fed-Fueled Rout as Stocks Struggle: Markets WrapEx-Goldman Bankers Make a Fortune With Controversial Bet on CoalMcCarthy Ambushed as Republican Hardliners Change Course on Spending PlanRaw Mea
- Investing.com
Global Weight-Loss Drug Market Projected to Hit $100 Billion by 2035
In a recent forecast, BMO Capital Markets has predicted the global market for innovative weight-loss drugs, such as Novo Nordisk (NYSE:NVO) A/S's Ozempic and Wegovy, to reach $100 billion by 2035. This projection follows an increase in patient recognition of the efficacy of these medications.
Motley FoolAre Wall Street Analysts Wrong About Eli Lilly Stock?
Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.
